St. Michael's Hospital ·
Area of research
Cardiology and Cardiovascular Medicine · Emergency Medicine
Research interest
Research interests include Atrial Fibrillation Management and Outcomes, Cardiac electrophysiology and arrhythmias, Cardiac pacing and defibrillation studies, and Cardiac Arrhythmias and Treatments.
Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry
Stroke risk in women with atrial fibrillation
Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation
Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry
Patient-Reported Outcomes in Atrial Fibrillation Research
Prevention of Arrhythmia Device Infection Trial
2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm
Meta-Analysis Comparing Neurohumoral Antagonist Use in Patients ≥75 Years Versus <75 Years Receiving Cardiac Resynchronization Therapy
P4591Outcomes of stable coronary artery disease worldwide. Insights from the CLARIFY registry
Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation
Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest
Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest
Fludrocortisone for the Prevention of Vasovagal Syncope
Increased atrial arrhythmia susceptibility induced by intense endurance exercise in mice requires TNFα
Atrial Fibrillation in Patients with Cryptogenic Stroke
2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
Amiodarone, Anticoagulation, and Clinical Events in Patients With Atrial Fibrillation
Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
Resuscitation Outcomes Consortium–Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial
Greater Mortality Risk Among Patients With Delayed Follow-up After Implantable Cardioverter Defibrillator Procedures
Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)
A Population-Based Description of Atrial Fibrillation in the Emergency Department, 2002 to 2010
Interpreting changes in quality of life in atrial fibrillation: How much change is meaningful?
Randomized Cluster Crossover Trials for Reliable, Efficient, Comparative Effectiveness Testing: Design of the Prevention of Arrhythmia Device Infection Trial (PADIT)